<DOC>
	<DOCNO>NCT00145522</DOCNO>
	<brief_summary>This study evaluate effect continuously combine 17b-estradiol/dydrogesterone comparison tibolone breast metabolic marker , particular total insulin-like growth factor-1 ( IGF-1 ) , postmenopausal woman .</brief_summary>
	<brief_title>Study Compare Effect Hormone Replacement Therapy ( HRT ) Breast Cardiovascular Metabolic Markers Postmenopausal Women</brief_title>
	<detailed_description />
	<mesh_term>Tibolone</mesh_term>
	<mesh_term>Dydrogesterone</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<criteria>Natural surgical postmenopausal amenorrhea since â‰¥ 12 month , non hysterectomized woman , complain least 14 hot flush per week Known , suspected history breast cancer hormonedependent neoplasia , undiagnosed genital bleeding , venous arterial history presence thromboembolism , cerebrovascular disease</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>Menopause , IGF-1 , HRT</keyword>
</DOC>